Summary:
To find out how safe and effective the study drug is when used for the treatment of moderate or severe migraine headaches.
Qualified Participants Must:
• be between 18-65 years of age
• suffer from 2-6 moderate to severe migraines per month
• be otherwise in good health
Qualified Participants May Receive:
up to $100 for completed study